These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30394691)

  • 1. Population-based surveillance of congenital heart defects among adolescents and adults: surveillance methodology.
    Glidewell J; Book W; Raskind-Hood C; Hogue C; Dunn JE; Gurvitz M; Ozonoff A; McGarry C; Van Zutphen A; Lui G; Downing K; Riehle-Colarusso T
    Birth Defects Res; 2018 Nov; 110(19):1395-1403. PubMed ID: 30394691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of Congenital Heart Defects among Adolescents at Three U.S. Sites.
    Lui GK; McGarry C; Bhatt A; Book W; Riehle-Colarusso TJ; Dunn JE; Glidewell J; Gurvitz M; Hoffman T; Hogue CJ; Hsu D; Obenhaus S; Raskind-Hood C; Rodriguez FH; Zaidi A; Van Zutphen AR
    Am J Cardiol; 2019 Jul; 124(1):137-143. PubMed ID: 31030970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Pregnancy, Gestational Complications, and Co-morbidities in Women With Congenital Heart Defects (Data from ICD-9-CM Codes in 3 US Surveillance Sites).
    Raskind-Hood C; Saraf A; Riehle-Colarusso T; Glidewell J; Gurvitz M; Dunn JE; Lui GK; Van Zutphen A; McGarry C; Hogue CJ; Hoffman T; Rodriguez Iii FH; Book WM
    Am J Cardiol; 2020 Mar; 125(5):812-819. PubMed ID: 31902476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Adults With Congenital Heart Defects in the United States.
    Gurvitz M; Dunn JE; Bhatt A; Book WM; Glidewell J; Hogue C; Lin AE; Lui G; McGarry C; Raskind-Hood C; Van Zutphen A; Zaidi A; Jenkins K; Riehle-Colarusso T
    J Am Coll Cardiol; 2020 Jul; 76(2):175-182. PubMed ID: 32646567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Capture-Recapture Methodology to Estimate Prevalence of Congenital Heart Defects Among Adolescents in 11 New York State Counties: 2008 to 2010.
    Akkaya-Hocagil T; Hsu WH; Sommerhalter K; McGarry C; Van Zutphen A
    Birth Defects Res; 2017 Nov; 109(18):1423-1429. PubMed ID: 28802092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program.
    Riehle-Colarusso T; Strickland MJ; Reller MD; Mahle WT; Botto LD; Siffel C; Atkinson M; Correa A
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):743-53. PubMed ID: 17990334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Usage Among Adolescents With Congenital Heart Defects at 5 Sites in the United States, 2011 to 2013.
    Lui GK; Sommerhalter K; Xi Y; Botto LD; Crume T; Farr S; Feldkamp ML; Glidewell J; Hsu D; Khanna A; Krikov S; Li J; Raskind-Hood C; Sarno L; Van Zutphen AR; Zaidi A; Soim A; Book WM
    J Am Heart Assoc; 2022 Sep; 11(18):e026172. PubMed ID: 36102252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-level surveillance of congenital heart defects among adolescents and adults in Colorado: Implications of record linkage.
    Crume TL; Duca LM; Ong T; Kraus E; Scott K; Khanna A; Kao D; Rausch CM; McKenzie L; Daley MF; Coleman S; Kahn MG; Costa E; Davidson AJ
    Am Heart J; 2020 Aug; 226():75-84. PubMed ID: 32526532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the prevalence of congenital heart disease among adolescents and adults in Colorado adjusted for incomplete case ascertainment.
    Duca LM; Pyle L; Khanna AD; Ong T; Kahn MG; DiGuiseppi C; Scott K; Daley MF; Costa E; Davidson AJ; Crume TL
    Am Heart J; 2020 Mar; 221():95-105. PubMed ID: 31955128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individuals aged 1-64 years with documented congenital heart defects at healthcare encounters, five U.S. surveillance sites, 2011-2013.
    Jill Glidewell M; Farr SL; Book WM; Botto L; Li JS; Soim AS; Downing KF; Riehle-Colarusso T; D'Ottavio AA; Feldkamp ML; Khanna AD; Raskind-Hood CL; Sommerhalter KM; Crume TL
    Am Heart J; 2021 Aug; 238():100-108. PubMed ID: 33951414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital discharge data: can it serve as the sole source of case ascertainment for population-based birth defects surveillance programs?
    Wang Y; Cross PK; Druschel CM
    J Public Health Manag Pract; 2010; 16(3):245-51. PubMed ID: 20357611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of adolescent and adult congenital heart defect prevalence in metropolitan Atlanta, 2010, using capture-recapture applied to administrative records.
    Raskind-Hood C; Hogue C; Overwyk KJ; Book W
    Ann Epidemiol; 2019 Apr; 32():72-77.e2. PubMed ID: 30602414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximity to Pediatric Cardiac Surgical Care among Adolescents with Congenital Heart Defects in 11 New York Counties.
    Sommerhalter KM; Insaf TZ; Akkaya-Hocagil T; McGarry CE; Farr SL; Downing KF; Lui GK; Zaidi AN; Van Zutphen AR
    Birth Defects Res; 2017 Nov; 109(18):1494-1503. PubMed ID: 29152921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the Classification of Congenital Heart Defects for Outcome Association Studies in Birth Defects Registries.
    Stephens SB; Benjamin RH; Lopez KN; Anderson BR; Lin AE; Shumate CJ; Nembhard WN; Morris SA; Agopian AJ
    Birth Defects Res; 2024 Aug; 116(8):e2393. PubMed ID: 39169811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient admissions and costs for adolescents and young adults with congenital heart defects in New York, 2009-2013.
    Hsu WH; Sommerhalter KM; McGarry CE; Farr SL; Downing KF; Lui GK; Zaidi AN; Hsu DT; Van Zutphen AR
    Birth Defects Res; 2021 Jan; 113(2):173-188. PubMed ID: 32990389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-Based Estimates of the Prevalence of Children With Congenital Heart Disease and Associated Comorbidities in the United States.
    Parker DM; Stabler ME; MacKenzie TA; Zimmerman MS; Shi X; Everett AD; Bucholz EM; Brown JR
    Circ Cardiovasc Qual Outcomes; 2024 Sep; 17(9):e010657. PubMed ID: 39185543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of congenital malformations surveillance in New York State: an application of Centers for Disease Control and Prevention (CDC) guidelines for evaluating surveillance systems.
    Sekhobo JP; Druschel CM
    Public Health Rep; 2001; 116(4):296-305. PubMed ID: 12037258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holt Oram syndrome: a registry-based study in Europe.
    Barisic I; Boban L; Greenlees R; Garne E; Wellesley D; Calzolari E; Addor MC; Arriola L; Bergman JE; Braz P; Budd JL; Gatt M; Haeusler M; Khoshnood B; Klungsoyr K; McDonnell B; Nelen V; Pierini A; Queisser-Wahrendorf A; Rankin J; Rissmann A; Rounding C; Tucker D; Verellen-Dumoulin C; Dolk H
    Orphanet J Rare Dis; 2014 Oct; 9():156. PubMed ID: 25344219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Well Do
    Rodriguez FH; Raskind-Hood CL; Hoffman T; Farr SL; Glidewell J; Li JS; D'Ottavio A; Botto L; Reeder MR; Hsu D; Lui GK; Sullivan AM; Book WM
    J Am Heart Assoc; 2022 Aug; 11(15):e024911. PubMed ID: 35862148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.
    Do TN; Street N; Donnelly J; Adams MM; Cunniff C; Fox DJ; Weinert RO; Oleszek J; Romitti PA; Westfield CP; Bolen J;
    Birth Defects Res; 2018 Nov; 110(19):1404-1411. PubMed ID: 30070776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.